Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

At The Institute of Cancer Research, London, we often refer to abiraterone as one of our greatest success stories. Discovered in one of our labs around 30 years ago, abiraterone has now become a ...

“New breast cancer drug capivasertib is allowing me to live life to the full” – Elen’s story“New breast cancer drug capivasertib is allowing me to live life to the full” – Elen’s story Elen Hughes was ...

Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escapeImage of human melanoma tissue, with melanoma cells in green and purple ...

Scientists from the ICR have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for ...

Doctors could soon be able to better predict an individual patient’s chances of getting cancer and offer them personalised detection and prevention strategies, thanks to a new research project co-led ...

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer.

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...